TickerFacts.

Fortrea Holdings Inc. (FTRE): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$794.60M
Year ended 2025-12-31
$67.50M
Trailing 12 months to 2026-06-30
$280.70M2021-12-31: $280.60M2022-12-31: $280.70M2023-12-31: $130.00M2024-12-31: -$75.00M2025-12-31: -$794.60M-$794.60M
2021-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$794.60Mn/m2026-02-26, From 2025-01-01
2024-12-31-$75.00Mn/m2026-02-26, From 2024-01-01
2023-12-31$130.00M-53.7%2026-02-26, From 2023-01-01
2022-12-31$280.70Mn/c2025-03-03, From 2022-01-01
2021-12-31$280.60Mn/a2024-03-13, From 2021-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Fortrea Holdings Inc. (FTRE)2025-12-31-$794.60Mn/m
Natera, Inc. (NTRA)2025-12-31-$268.15Mn/m
RadNet, Inc. (RDNT)2025-12-31$198.09M-13.8%
Guardant Health, Inc. (GH)2025-12-31-$397.51Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$67.73Mn/m
Quest Diagnostics Inc (DGX)2025-12-31$2.13B+15.6%
Labcorp Holdings Inc. (LH)2025-12-31$2.07B+19.4%
Veracyte, Inc. (VCYT)2025-12-31$79.19M+100.0%
CareDx, Inc. (CDNA)2025-12-31-$15.76Mn/m

Compare FTRE, NTRA, RDNT, GH side by side · Screen every company in Services-Medical Laboratories ↗